Hepatitis C Combination Therapy - Novelos Therapeutics Gets Green Light from FDA for Phase 3 Development in Lung Cancer

Novelos Therapeutics Gets Green Light from FDA for Phase 3 Development in Lung Cancer
New Age Media Concepts - cancer and our second compound, NOV-205, targeting chronic hepatitis C.' ' We are pleased that the FDA has considered

Consensus IFN+ IFN Gamma-1b in African-American Peg Nonresponders
National AIDS Treatment Advocacy Project - larger patient population ABSTRACT ground: Therapy for chronic hepatitis C with pegylated interferon alfa-2 plus

Teva Announces Final Approval of Ribavirin Tablets
Pharma Live - peginterferon alfa-2a for treatment of adults with chronic hepatitis C virus who have compensated liver disease and have

Peregrine Pharmaceuticals, Inc. (PPHM) Names Leading Viral Experts To Its Scientific Resource Board
BioSpace - a Phase I clinical trial for the treatment of chronic hepatitis C infection (HCV) and is being studied preclinically for